AU2015249177B2 — Composition comprising a serotonin receptor agonist and a diketopiperazine for treating migraines
Assigned to Mannkind Corp · Expires 2017-08-03 · 9y expired
What this patent protects
(54) Th COMPOSTION 0MPRISING A SFROTON]N REGEPTOR AGONIST AND A DKETGPW[EALE FOR TREATING MiRAIN 51 lb *1 't (5) rtme ein in liila Tinekie gd dNbTh iisi e rapdTa Abthat:Armp fitatict nifc tarn&P _ , S .' , 5 's''f Itj iiT tc m,1KS menirnent.vst i ine tieiar ae hru n'iei oftt …
USPTO Abstract
(54) Th COMPOSTION 0MPRISING A SFROTON]N REGEPTOR AGONIST AND A DKETGPW[EALE FOR TREATING MiRAIN 51 lb *1 't (5) rtme ein in liila Tinekie gd dNbTh iisi e rapdTa Abthat:Armp fitatict nifc tarn&P _ , S .' , 5 's''f Itj iiT tc m,1KS menirnent.vst i ine tieiar ae hru n'iei oftt dr i he p unr rct sIC lkY delt ctLtk:C-1
Drugs covered by this patent
- Remodulin (TREPROSTINIL) · United Therap
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.